SS patients exhibit excessive activation of monocytic and macrophagic inflammasomes, notably NLRP3 (22), Moreover, along with the activation of the NLRP3 inflammasome and subsequent IL-18 secretion in salivary glands significantly enhance innate immune responses (24). Here, NLRP3 is linked to synovial sarcoma.